ResMed Inc. ResMed Inc.

ResMed Inc.

RMD

Classement en actions #724
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Prix de l'action
$238.47
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$33.54B
Changement (1 jour)
-1.59%
Changement (1 an)
-11.05%
Pays
US
Échange ResMed Inc. (RMD)

Catégorie

Healthcare
Marge opérationnelle de ResMed Inc. (RMD)
Marge opérationnelle au October 2026 TTM : 33.48%
Selon les derniers rapports financiers et le cours de l'action de ResMed Inc., la marge opérationnelle actuelle (TTM) est de 33.48%. À la fin de 2024, elle était de 28.17%.
Historique de la marge opérationnelle pour ResMed Inc. de 2000 à 2026
Marge opérationnelle à la fin de chaque année
Année Marge opérationnelle Changez
2026 (TTM) 33.48% 2.23%
2025 32.75% 16.26%
2024 28.17% 5.11%
2023 26.80% -4.15%
2022 27.96% -1.10%
2021 28.27% 3.25%
2020 27.38% 23.22%
2019 22.22% -4.02%
2018 23.15% 12.38%
2017 20.60% -11.70%
2016 23.33% -4.31%
2015 24.38% -6.41%
2014 26.05% 11.18%
2013 23.43% 8.93%
2012 21.51% 0.19%
2011 21.47% -2.45%
2010 22.01% 6.48%
2009 20.67% 20.81%
2008 17.11% 35.90%
2007 12.59% -41.79%
2006 21.63% -5.46%
2005 22.88% -9.06%
2004 25.16% 2.36%
2003 24.58% -198.05%
2002 -25.07% -249.40%
2001 16.78% -41.45%
2000 28.66% 0.00%
Marge opérationnelle pour des entreprises similaires ou concurrentes
Entreprise Marge opérationnelle Différence de Marge Opérationnelle Pays
17.03% -99.49%
US
17.86% -99.47%
IE
22.03% -99.34%
US
21.46% -99.36%
US
0.00% -
DE
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.